Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis

For chronic hepatitis B (CHB), alanine aminotransferase (ALT) ≥2 × upper limit of normal (ULN) is often used as a major criteria to initiate treatment in absence of cirrhosis, though patients with lower ALT may not be free from future risk of hepatocellular carcinoma (HCC). We aimed to examine the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoang, Joseph K., Yang, Hwai-I, Le, An, Nguyen, Nghia H., Lin, Derek, Vu, Vinh D., Chaung, Kevin, Nguyen, Vincent, Trinh, Huy N., Li, Jiayi, Zhang, Jian Q., Chen, Chien-Jen, Nguyen, Mindie H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979821/
https://www.ncbi.nlm.nih.gov/pubmed/27495067
http://dx.doi.org/10.1097/MD.0000000000004433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979821/
https://www.ncbi.nlm.nih.gov/pubmed/27495067
http://dx.doi.org/10.1097/MD.0000000000004433

Ejemplares similares